These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17227970)

  • 1. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Zhan H; Zheng H
    JAMA; 2007 Jan; 297(3):261-2; author reply 263. PubMed ID: 17227970
    [No Abstract]   [Full Text] [Related]  

  • 2. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Harrington DW; Jindeel A
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227972
    [No Abstract]   [Full Text] [Related]  

  • 3. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Bhala N; Shah A; King A; Molugu C
    JAMA; 2007 Jan; 297(3):261; author reply 263. PubMed ID: 17227971
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Edwards JL
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227973
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism.
    Bernardi E; Prandoni P
    Curr Opin Pulm Med; 2005 Sep; 11(5):363-7. PubMed ID: 16093806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for venous thromboembolism. What are the current options?
    Yacovella T; Alter M
    Postgrad Med; 2000 Sep; 108(4):43-6, 51-4. PubMed ID: 11021258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
    Kearon C; Ginsberg JS; Julian JA; Douketis J; Solymoss S; Ockelford P; Jackson S; Turpie AG; MacKinnon B; Hirsh J; Gent M;
    JAMA; 2006 Aug; 296(8):935-42. PubMed ID: 16926353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis.
    Coutinho JM; Ferro JM; Canhão P; Barinagarrementeria F; Bousser MG; Stam J;
    Stroke; 2010 Nov; 41(11):2575-80. PubMed ID: 20930161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Low molecular weight heparin or unfractionated heparin in the treatment of patients with uncomplicated deep vein thrombosis.
    Lane B; Harrison M
    J Accid Emerg Med; 2000 Nov; 17(6):402-3. PubMed ID: 11104240
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
    Riess H; Becker LK; Melzer N; Harenberg J
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):838-44. PubMed ID: 25004024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.
    Hull RD; Pineo GF
    Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-basis for anticoagulants for cerebral sinus venous thrombosis?
    Cundiff DK
    Stroke; 2013 Jun; 44(6):e67. PubMed ID: 23592764
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of action and pharmacology of unfractionated heparin.
    Hirsh J; Anand SS; Halperin JL; Fuster V
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1094-6. PubMed ID: 11451734
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.